One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Cardiac Biomarkers, Intensive Lifestyle Intervention, and Heart Failure Subtypes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study
doi : 10.1016/j.jchf.2025.102726
Volume 14, Issue 3, March 2026, 102726
Looking AHEAD to Heart Failure Prevention: The Role of NT-proBNP and Lifestyle Modification
doi : 10.1016/j.jchf.2025.102732
Volume 14, Issue 3, March 2026, 102732
A Novel Computational Pipeline for Acquiring Pressure-Volume Hemodynamics of the Right Ventricle in Pulmonary Hypertension
doi : 10.1016/j.jchf.2025.102753
Volume 14, Issue 3, March 2026, 102753
Practical Application of Pressure-Volume Loops and Cardiac Energetics to Improve Care Delivery in Pulmonary Hypertension: Have We Finally Found the “RIGHT” Toolbox?
doi : 10.1016/j.jchf.2025.102781
Volume 14, Issue 3, March 2026, 102781
Mechanically Reducing Cardiac Preload With the preCARDIA System in Acutely Decompensated Heart Failure
doi : 10.1016/j.jchf.2025.102841
Volume 14, Issue 3, March 2026, 102841
Venting the Venous Circulation: A Novel Approach to Decongestion in Heart Failure
doi : 10.1016/j.jchf.2025.102840
Volume 14, Issue 3, March 2026, 102840
Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and Outcomes
doi : 10.1016/j.jchf.2025.102768
Volume 14, Issue 3, March 2026, 102768
BMI in HFpEF: Friend or Foe?
doi : 10.1016/j.jchf.2025.102826
Volume 14, Issue 3, March 2026, 102826
Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 Trial
doi : 10.1016/j.jchf.2025.102769
Volume 14, Issue 3, March 2026, 102769
Guideline-Directed Medical Therapy for Patients With a Left Ventricular Assist Device: The Time Is Now
doi : 10.1016/j.jchf.2025.102853
Volume 14, Issue 3, March 2026, 102853
Long-Term Outcomes in Women With a History of Peripartum Cardiomyopathy
doi : 10.1016/j.jchf.2025.102702
Volume 14, Issue 3, March 2026, 102702
Peripartum Cardiomyopathy: Lessons From Long-Term Outcomes in Israel
doi : 10.1016/j.jchf.2025.102818
Volume 14, Issue 3, March 2026, 102818
Bringing Advanced Heart Failure Therapies to Veterans: A Call to Action
doi : 10.1016/j.jchf.2025.102713
Volume 14, Issue 3, March 2026, 102713
Current Use of Inotropic Support in Cardiogenic Shock: Physiological Targets for the First Line of Defense
doi : 10.1016/j.jchf.2025.102725
Volume 14, Issue 3, March 2026, 102725
Assessing Medical Therapy Optimization in Cardiovascular-Kidney-Metabolic Clinical Trials: An Initiative From the Heart Failure Collaboratory
doi : 10.1016/j.jchf.2025.102727
Volume 14, Issue 3, March 2026, 102727
Vericiguat: VICTORy or Defeat?
doi : 10.1016/j.jchf.2025.102763
Volume 14, Issue 3, March 2026, 102763
Undetected Heart Failure in Tertiary Care/Cardiology in Switzerland
doi : 10.1016/j.jchf.2025.102733
Volume 14, Issue 3, March 2026, 102733
In-Hospital Virtual Consultation to Implement Guideline-Directed Medical Therapy for Cardiovascular-Kidney-Metabolic Disease: The IMPLEMENT-CRM Randomized Trial
doi : 10.1016/j.jchf.2025.102755
Volume 14, Issue 3, March 2026, 102755
Hyperkalemia-Related Heart Failure Therapy Discontinuation and the Association With Outcomes in Patients With Heart Failure
doi : 10.1016/j.jchf.2025.102740
Volume 14, Issue 3, March 2026, 102740
From Zero to Zero Sum: Heart Offers in the Donation After Circulatory Death Era
doi : 10.1016/j.jchf.2025.102759
Volume 14, Issue 3, March 2026, 102759
Policy Changes for Progress: Turning DCD Innovations Into More Heart Transplants
doi : 10.1016/j.jchf.2026.102955
Volume 14, Issue 3, March 2026, 102955
Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction
doi : 10.1016/j.jchf.2025.102771
Volume 14, Issue 3, March 2026, 102771
Pre-LVAD tMCS: The Overlooked Burden of Bleeding
doi : 10.1016/j.jchf.2025.102896
Volume 14, Issue 3, March 2026, 102896
REPLY: Pre-LVAD tMCS: The Overlooked Burden of Bleeding
doi : 10.1016/j.jchf.2025.102893
Volume 14, Issue 3, March 2026, 102893
